Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 4, 2007, Pages 417-418

  Niks, Erik H ^a   Kuks, Jan B M ^b   Verschuuren, Jan J G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; MUSCLE SPECIFIC KINASE ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYASTHENIA GRAVIS; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; CHILD; IMMUNOLOGY; INCIDENCE; INFANT; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NETHERLANDS; PREVALENCE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 33947728100     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.102517     Document Type: Article

References (10)

1. Sanders DB, El Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978.
2. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11.
3. McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004;55:580-4.
4. Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 2005;12:413-18.
5. Yeh JH, Chen WH, Chiu HC, et al. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 2004;62:2131-2.
6. Wirtz PW, Nijnuis MG, Sotodeh M, et al. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol 2003;250:698-701.
7. Limburg PC, The TH, Hummel-Tappel E, et al. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J Neurol Sci 1983;58:357-70.
8. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233-8.
9. Tron F, Gilbert D, Mouquet H, et al. Genetic factors in pemphigus. J Autoimmun 2005;24:319-328.
10. Niks EH, Kuks JBM, Roep BO, et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 2006;66:1772-4.